稻草还田对土壤微生物群落功能多样性的影响

为了探讨稻草还田的微生物学过程与效应,借助平板涂抹法和BIOLOG检测法,比较研究了免耕条件下3种不同稻草还田量(33%、67%和100%,以稻草不还田土壤为对照)对晚稻田土壤微生物群落功能多样性的影响.结果表明:①土壤细菌数量差异显著,以67%稻草还田处理为最高,稻草不还田处理最低,稻草还田提高了土壤细菌数量;②碳源平均颜色变化率(AWCD法)在培养早期各处理间的差异不大,但随着培养时间的延长,67%和100%稻草还田处理土壤微生物的AWCD值显著大于对照和33%稻草还田处理组;③土壤微生物代谢多样性指数(丰富度和多样性)在3种稻草还田量处理土壤中也表现出明显差异,67%和100%稻草还田处理的土壤中微生物功能多样性显著大于33%稻草还田处理和对照;④67%和100%稻草还田处理显著改善了土壤微生物的功能多样性.以67%稻草还田处理改善土壤微生物群落结构和功能的效果最为显著.     

曝气生物滤池中碳和氮代谢特性

用充填陶瓷滤料的曝气生物滤池研究碳和氮代谢特性。曝气生物滤池进水氨氮为52mg／L左右、COD为100mg／L左右和回流比为200％时,经过20多d的运行,出水氨氮小于0．05mg／L、COD小于25mg／L、亚硝态氮为4．7mg／L和硝态氮为7．1mg／L,COD去除率达75％,氨氮去除率达99．9％,总氮去除率达78％;过大和过小的回流比对曝气生物滤池的运行性能都是不利的。研究成果可以应用于一般城市污水以及含低COD、高氨氮工业废水的处理。     

沼泽产甲烷能力和途径差异的机制

土壤中甲烷的形成有 2条途径 :乙酸发酵和H2 /CO2 还原。比较而言 ,乙酸发酵产甲烷的能力强于H2 /CO2 还原。在特定环境中 ,何种产甲烷途径占优势取决于底物尤其是活性有机碳含量 ,而新形成的有机碳尤为重要。活性有机碳含量丰富的沼泽 ,甲烷主要由乙酸发酵形成 ,因此产甲烷能力较强。导致沼泽产甲烷能力异同的原因就是有效底物含量差异 ,从而使不同类型沼泽环境中产甲烷菌菌种不同 ,正是底物含量的高低和由此引起的产甲烷菌菌种的不同决定了不同类型沼泽产甲烷潜能的差异     

A model to predict concentration enrichment of contaminants on soil adhering to plants and skin

Transfer of soil contaminants into the food chain has long been a concern. However, certain aspects of the pathways involved have not been fully investigated. One is the enrichment of contaminant concentrations through physical processes such as size-sorting of soil particles. Fine particles selected from soil by processes such as adhesion onto plants will have much higher contaminant concentrations than the original soil. A saturation kinetics model of the process of soil adhesion to leaf surfaces was developed. The model helps identify the parameters that are least-well known and need experimental support. The ratio of clay and sand wash-off half times was especially important. With nominal values for the input parameters, estimated enrichments agreed well with observations to date, and ranged from slightly over unity for medium- and fine-textured soils to about tenfold for sandy soils. With a few reasonable assumptions, the model was generalised to apply to other soil adhesion scenarios such as adhesion to skin. The generalised model can be applied with minimal need for setting-specific information.     

甲胺磷农药的微生物降解

综述了甲胺磷降解菌的分布、类型及其实际应用，并介绍了微生物代谢甲胺磷的可能机制。     

微囊藻毒素生物降解的研究进展

蓝藻水华污染造成的最主要危害之一是产生和释放以微囊藻毒素(microcystins,MCs)为主的多种藻毒素,其在饮用水中的存在可以导致人类癌症,因此对人们的健康构成了严重威胁.从MCs降解微生物菌种、酶催化降解途径和降解基因3个方面,介绍了近年来国内外MCs生物降解的研究进展.     

Tetrasphaera聚磷菌研究进展及其除磷能力辨析

强化生物除磷（EBPR）工艺在污水脱氮除磷中扮演着重要角色，其机理研究与工程应用也较为成熟.长期以来，Accumulibacter菌属（A菌）作为EBPR工艺最主要的聚磷菌（PAOs）已被广泛接受.同时，具有聚磷能力的Tetrasphaera菌属（T菌）亦被发现，且在某些特定环境下其丰度甚至远高于A菌，进而引发业内一定的关注.本文通过对T菌发现、研究过程的梳理，总结了关于T菌丰度、代谢途径及影响其活性的因素等方面的研究成果.与A菌不同，T菌代谢途径具有多样性，可依赖发酵代谢进行细胞维持和增殖，其发酵产物甚至可以供给A菌利用.T菌可利用大分子有机物（如葡萄糖、氨基酸等）和VFAs（亲和性较低）进行厌氧释磷，继而完成好氧、甚至缺氧吸磷过程.T菌主要菌株（T.elongata）因缺少合成PHA相关酶基因而不能以PHA作为内聚产物在厌氧环境下储能；糖原和游离氨基酸被检测到可作为T菌的能源/碳源内聚物，但亦有结果相左的研究.借助于拉曼光谱技术，一些污水处理厂中T菌与A菌被证实对磷去除的贡献大小相当.总之，目前对T菌的研究还十分有限，现有研究仍不足以证明它们在EBPR中可稳定发挥除磷贡献.今后应在T菌不同代谢途径控制因素及所需环境条件方面进行深入研究，以确认T菌可否持续、稳定地实现除磷作用.     

Prenatal diagnosis of inherited metabolic disorders by quantitation of characteristic metabolites in amniotic fluid: Facts and future

An attempt is made to summarize as completely as possible what is known about the prenatal diagnosis of amino– and organic acidurias by direct measurement of characteristic metabolites in amniotic fluid, and to indicate which disorders can potentially be diagnosed prenatally by direct quantitation of metabolites. Furthermore, the disorders are mentioned in which the prenatal diagnosis was proven to be unsuccessful by this approach. The prenatal diagnoses of a case of propionic acidemia and a case of tyrosinemia type I in the 11th and 12th week of gestational age, respectively, are reported and the prospects of performing amniocentesis in the first trimester for prenatal diagnosis are discussed.     

First-trimester biochemical and molecular diagnoses using chorionic villi: High accuracy in the U.S. collaborative study

The accuracy of biochemical and molecular prenatal diagnoses using chorionic villi as the fetal source was assessed by seven centres participating in the NICHD collaborative study on the safety and accuracy of chorionic villus sampling (CVS) and amniocentesis. Of 601 pregnancies studied, biochemical methods were used to determine the diagnosis in 283 fetuses at risk for 35 different metabolic disorders. Fifteen different lysosomal storage diseases accounted for 81 per cent of the biochemical prenatal diagnoses performed, with 57 per cent of these pregnancies at risk for Tay-Sachs disease. No errors were made in the biochemical diagnoses that predicted affected or unaffected fetuses. However, the diagnoses of certain disorders (e.g., mucopolysacchariodosis type IH, metachromatic leukodystrophy, and Krabbe disease) occasionally required confirmatory studies in cultured amniocytes because the enzyme results were inconclusive in direct and/or cultured villi or due to the presence of a pseudodeficiency allele. Of these, only the diagnosis of a fetus at risk for Krabbe disease remained inconclusive after special studies to discriminate between mutant and pseudodeficiency alleles. Recombinant DNA techniques were used to predict the diagnosis of 318 fetuses at risk for 16 different disorders in which the defective disease gene could be detected either directly or by linkage analysis to a nearby polymorphic marker. Of these, 32 per cent were for haemoglobinopathies, 25 per cent for cystic fibrosis, 24 per cent for Duchenne or Becker muscular dystrophy, and 7 per cent for haemophilias. Pregnancies at risk for known disorders with specific molecular lesions (e.g., sickle cell disease) were accurately diagnosed in direct and/or cultured villi. Diagnoses requiring analyses with closely linked polymorphic markers were occasionally uninformative or inconclusive. Maternal contamination was not reported in any biochemical or molecular-based diagnosis. These studies document the high accuracy and rapidity of both biochemical and mutation-specific prenatal diagnoses with direct and cultured chorionic villi.